Docking-based virtual screening of anticancer drugs

Medicinal Plant Biotechnology

Volumn , Issue , 2010, Pages 244-266

  Khan, Feroz ^a   Meena, Abha ^a   Sharma, Ashok ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955776930     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (25)

1. Abagyan, R. and Totrov, M. (2001) High-throughput docking for lead generation. Current Opinion in Chemical Biology 5, 375-382.
2. Abagyan, R., Totrov, M. and Kuznetsov, D. (1994) ICM: A new method for structure modeling and design: Applications to docking and structure prediction from the distorted native conformation, Journal of Computational Chemistry 15, 488-506.
3. Ahmads N., Guptas S. and Mukhtar, H. (2000) Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappa B in cancer cells versus normal cells. Archives of Biochemistry and Biophysics 376, 338-346.
4. Anderson, S. and Chiplin, J. (2002) Structural genomics: Shaping the future of drug design? Drug Discovery Today 7, 105-107.
5. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The protein data bank. Nucleic Acids Research 28, 235-242.
6. Chen, X., Ji, Z.L. and Chen, Y.Z. (2002) TTD: Therapeutic Target Database. Nucleic Acids Research 30(1), 412-415
7. Chen, Y.Z. and Ungs, C.Y. (2001) Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. Journal of Molecular Graphics and Modelling 20(3), 199-218.
8. Chung, J.Y., Huang, C., Meng, X., Dong, Z. and Yang, C.S. (1999) Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: Structure-activity relationship and mechanism involved. Cancer Research 59, 4610-4617.
9. Demeule, M., Buossard, M., Page, M., Ginruas, D. and Beliveau, R. (2000) Matrix metalloproteinase inhibition by green tea catechins. Biochimica et Biophysica Acta 1478, 51-60.
10. Eymin, B., Dubrez, L., Allouche, M. and Solary, E. (1997) Increased Gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. Cancer Research 57, 686-695.
11. Gane, P.J. and Dean, P.M. (2000) Recent advances in structure-based rational drug design. Current Opinion in Structural Biology 10, 401-404.
12. Klebe, G. (2000). Recent developments in structure-based drug design. Journal of Molecular Medicine (Berlin) 78, 269-281.
13. Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S.J. and Fujiki H. (1993). Anticarcinogenic activity of green tea polyphenols. Japanese Journal of Clinical Oncology 23(3), 186-90.
14. Liang, Y.C., Lin-Shiau, S.Y., Chen, C.F. and Lin J.K. (1997) Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. Journal of Cellular Biochemistry 67, 55-65.
15. Lipinski, C.A., Lombardo, F. and Dominy, B.W. (2000) Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods 44, 235-249.
16. Lipinski, C.A. et al. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23, 3-25.
17. Martelli, A.M., Bortul, R., Bareggi, R., Takelloni, G., Grill, V., Baldini, G. and Narducci, P. (1999) The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. Cancer Research 59, 3961-3967.
18. Matsumoto, Y., Gujiwara, T. and Nago, S. (1995) Determinants of drug response in camptothecinresistant glioma cell lines. Journal of Neurooncology 23, 1-8.
19. Nieves-Neira, W. and Pommier, Y. (1999) Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the eight human breast cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase 1, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathway. International Journal of Cancer 82, 396-404.
20. Shoichet, B.K., McGovern, S.L., Wei, B. and Irwin, J.J. (2002) Lead discovery using molecular docking. Current Opinion in Chemical Biology 6, 439-446.
21. Sinha, B.K. (1995) Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs 49, 11-19.
22. Subramaniam, S., Mehrotra, M. and Gupta, D. (2008) Virtual high throughput screening (VHTS)-A perspective. Bioinformation 3(1), 14-17.
23. Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W. and Kopple, K.D. (2002) Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry 45, 2615-2623.
24. Walters, W.P., Stahl, M.T. and Murcko, M.A. (1998) Virtual screening-an overview. Drug Discovery Today 3, 160-178.
25. Wang, M.C., Liu, J.H. and Wang, F.F. (1997) Protein tyrosine phosphatase-dependent activation of β-globin and δ aminolevulenic acid synthase genes in the camptothecin-induced IW 32 erythroleukemia cell differentiation. Molecular Pharmacology 51, 558-566.